New hope for Hard-to-Treat colorectal cancer: Triple-Drug combo targets liver tumors
NCT ID NCT07550088
First seen Apr 28, 2026 · Last updated May 13, 2026 · Updated 5 times
Summary
This study tests a combination of three drugs (balstilimab, botensilimab, and agenT-797) in adults with a type of colorectal cancer that has spread to the liver and hasn't responded to prior treatments. The goal is to see if the combination can shrink tumors and what side effects occur. All 17 participants will receive the treatment; there is no placebo group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Scripps Clinic Torrey Pines
La Jolla, California, 92037, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.